By IANS
Mumbai : Orchid Chemicals and Pharmaceuticals Ltd Wednesday said it has received an approval from US Food and Drug Administration (US FDA) for its Cefuroxime Axetil tablets.
Orchid’s statement to the Bombay Stock Exchange (BSE,) said the product, falling under the ANDA (Abbreviated New Drug Application), is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
According to company officials, this is the 25th ANDA approval that the company has received since it started its US Generics journey in 2005.
Last week the Chennai-based pharma company had announced about the approval from US FDA in regard to its anti-emetic and non-antibiotic Granisetron Hydrochloride tablets. The product is available in 1 mg dosage strength.